Vimarsana
Biggest News Aggregation in the World

B Merck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B Merck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Merck Today - Breaking & Trending Today

Merck sues to stop Biden's drug-negotiation program, calls it 'extortion' - Vimarsana News

Merck sues to stop Biden's drug-negotiation program, calls it 'extortion'

Drugmaker Merck & Co. filed a lawsuit Tuesday alleging President Biden's marquee effort to negotiate down the cost of drugs under Medicare is "tantamount to extortion" and violates the Constitution.

Johnson & Johnson paused COVID-19 vaccine product at Dutch plant: Report - Vimarsana News

Johnson & Johnson paused COVID-19 vaccine product at Dutch plant: Report

Johnson & Johnson reportedly shut down the only plant making usable batches of its COVID-19 vaccine even though many poor and developing nations are relying on the shots to immunize their populations.

Johnson & Johnson paused COVID-19 vaccine product at Dutch plant: Report - Vimarsana News

Johnson & Johnson paused COVID-19 vaccine product at Dutch plant: Report

Johnson & Johnson reportedly shut down the only plant making usable batches of its COVID-19 vaccine even though many poor and developing nations are relying on the shots to immunize their populations.

FDA panel narrowly backs COVID-19 pill from Merck - Vimarsana News

FDA panel narrowly backs COVID-19 pill from Merck

A panel of U.S. health advisers on Tuesday narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the virus.

FDA: Merck COVID-19 pill effective, experts will review safety - Vimarsana News

FDA: Merck COVID-19 pill effective, experts will review safety

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems in pregnant women.